DoD Breast Cancer, Breakthrough Award Levels 1 and 2
ID: 354866Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354866
Timeline
    Description

    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY24 Breast Cancer Breakthrough Award Levels 1 and 2 to support innovative research aimed at making significant advancements in breast cancer treatment and prevention. This grant opportunity encourages high-risk, high-reward projects that can lead to breakthroughs in understanding cancer mechanisms and improving health outcomes, particularly for military personnel and the general public. With an estimated total program funding of $12.6 million, the program anticipates awarding approximately eight grants, with funding limits of up to $750,000 for Level 1 and up to $1.5 million for Level 2 applications. Interested applicants must submit a pre-application by September 26, 2024, and can reach the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524BCRPBTA122-GG.pdf
    The Department of Defense (DOD) announces the FY24 Breast Cancer Breakthrough Award Levels 1 and 2 through the Congressionally Directed Medical Research Programs (CDMRP), aiming to accelerate high-impact research in breast cancer. The program, which has appropriated $150 million for FY24, encourages innovative projects that address significant challenges in breast cancer, such as prevention, understanding cancer mechanisms, and improving treatment strategies. Eligible applicants include various organizations, both domestic and international, and any investigator may serve as Principal Investigator. A two-step application process involves a pre-application and full application, with specific funding limits for each award level: Level 1 (up to $750,000 for partnering PIs) and Level 2 (up to $1.5 million). Applications are evaluated based on impact, feasibility, personnel qualifications, and innovation, and must align with strategic research goals. Final awards will be granted by September 30, 2025, based on the availability of funds and application merit. This program exemplifies the government’s commitment to advancing cancer research and improving health outcomes for military personnel and the general public.
    Similar Opportunities
    DoD Breast Cancer, Transformative Breast Cancer Consortium Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Transformative Breast Cancer Consortium Development Award, aimed at fostering innovative research to combat breast cancer. This grant supports the establishment of a consortium framework that brings together scientists, clinicians, and breast cancer advocates to conduct preliminary research, with a focus on developing infrastructure, acquiring resources, and generating necessary preliminary data. The program emphasizes collaboration across institutions, particularly in addressing women's health issues and advancing knowledge relevant to military families and veterans. Interested applicants can apply for up to $100,000 in direct costs, with applications due by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Breast Cancer, Clinical Research Extension Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Breast Cancer Clinical Research Extension Award, a federal grant aimed at enhancing the impact of breast cancer clinical studies. This grant seeks to extend data collection and analysis from existing clinical trials, focusing on improving patient follow-up and addressing knowledge gaps due to early trial terminations. The program is critical for advancing breast cancer research and ensuring that patient contributions are effectively utilized to save lives. With an estimated total funding of $9.3 million, the award will support one application, with a maximum budget of $5 million for single Principal Investigators or $6 million for those utilizing the Partnering PI option. Interested applicants must submit a pre-application by September 12, 2024, and a full application by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for Fiscal Year 2024. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address urgent issues in cancer research, specifically targeting at least three distinct cancer areas while integrating diverse scientific methodologies. With an estimated total program funding of $32 million and a single award anticipated, applicants must submit a pre-application followed by a full application upon invitation, with the closing date for submissions set for October 15, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Bone Marrow Failure, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Bone Marrow Failure Research Program (BMFRP) Investigator-Initiated Research Award, aimed at advancing research on bone marrow failure (BMF) diseases. This grant opportunity includes two funding levels: Funding Level 1 (FL1) focuses on developing mature ideas and translating discoveries into clinical applications, while Funding Level 2 (FL2) supports efforts to facilitate Investigational New Drug (IND) applications for promising therapeutic candidates. With a total estimated funding of $2.44 million available for two awards, the program encourages innovative and collaborative research proposals that address critical questions in BMF disease management. Interested applicants must submit a pre-application by July 17, 2024, with the full application due by October 9, 2024; for assistance, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Bone Marrow Failure, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Bone Marrow Failure Research Program (BMFRP) Idea Development Award for FY24, aimed at supporting innovative research to understand and cure bone marrow failure diseases. This grant opportunity encourages both Established Investigators and Early-Career Investigators to propose high-impact research studies with a strong scientific rationale, focusing on conditions such as Aplastic Anemia and Fanconi Anemia, while excluding funding for clinical trial costs. With an estimated total program funding of $4.24 million and the expectation of awarding five grants, interested applicants must submit a pre-application through eBRAP followed by a full application via Grants.gov by the deadline of October 9, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.